Author
Listed:
- Jordi Bonaventura
(National Institute on Drug Abuse Intramural Research Program)
- Mark A. G. Eldridge
(National Institute of Mental Health Intramural Research Program)
- Feng Hu
(Department of Radiology Johns Hopkins School of Medicine)
- Juan L. Gomez
(National Institute on Drug Abuse Intramural Research Program)
- Marta Sanchez-Soto
(National Institute of Neurological Disorders and Stroke Intramural Research Program)
- Ara M. Abramyan
(National Institute on Drug Abuse Intramural Research Program)
- Sherry Lam
(National Institute on Drug Abuse Intramural Research Program)
- Matthew A. Boehm
(National Institute on Drug Abuse Intramural Research Program)
- Christina Ruiz
(University of California)
- Mitchell R. Farrell
(University of California)
- Andrea Moreno
(Aarhus University)
- Islam Mustafa Galal Faress
(Aarhus University)
- Niels Andersen
(Aarhus University)
- John Y. Lin
(University of Tasmania)
- Ruin Moaddel
(National Institute on Aging Intramural Research Program)
- Patrick J. Morris
(National Center for Advancing Translational Sciences)
- Lei Shi
(National Institute on Drug Abuse Intramural Research Program)
- David R. Sibley
(National Institute of Neurological Disorders and Stroke Intramural Research Program)
- Stephen V. Mahler
(University of California)
- Sadegh Nabavi
(Aarhus University)
- Martin G. Pomper
(Department of Radiology Johns Hopkins School of Medicine)
- Antonello Bonci
(National Institute on Drug Abuse Intramural Research Program)
- Andrew G. Horti
(Department of Radiology Johns Hopkins School of Medicine)
- Barry J. Richmond
(National Institute of Mental Health Intramural Research Program)
- Michael Michaelides
(National Institute on Drug Abuse Intramural Research Program
Johns Hopkins School of Medicine)
Abstract
Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) are a popular chemogenetic technology for manipulation of neuronal activity in uninstrumented awake animals with potential for human applications as well. The prototypical DREADD agonist clozapine N-oxide (CNO) lacks brain entry and converts to clozapine, making it difficult to apply in basic and translational applications. Here we report the development of two novel DREADD agonists, JHU37152 and JHU37160, and the first dedicated 18F positron emission tomography (PET) DREADD radiotracer, [18F]JHU37107. We show that JHU37152 and JHU37160 exhibit high in vivo DREADD potency. [18F]JHU37107 combined with PET allows for DREADD detection in locally-targeted neurons, and at their long-range projections, enabling noninvasive and longitudinal neuronal projection mapping.
Suggested Citation
Jordi Bonaventura & Mark A. G. Eldridge & Feng Hu & Juan L. Gomez & Marta Sanchez-Soto & Ara M. Abramyan & Sherry Lam & Matthew A. Boehm & Christina Ruiz & Mitchell R. Farrell & Andrea Moreno & Islam , 2019.
"High-potency ligands for DREADD imaging and activation in rodents and monkeys,"
Nature Communications, Nature, vol. 10(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-12236-z
DOI: 10.1038/s41467-019-12236-z
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-12236-z. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.